
    
      Condition: Patients submitted to coronary revascularization characterized for glucose
      tolerance after OGTT Intervention: L-arginine for 6 months Inclusion criteria: patients in
      stable clinical conditions after coronary revascularization (CABG and percutaneous
      angioplasty with/without stent implantation). Age > 30 years, male and female. Fasting
      glucose levels below 126 mg/dl.

      Exclusion criteria. Type 1 diabetes mellitus, known type 2 diabetes mellitus, pregnancy,
      impaired kidney and liver function, severe and not treated arterial hypertension.

      Study type: randomized, double blind, Placebo, parallel
    
  